ImageneBio, Inc. (IMA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.83
• Market Cap: $91.69M
• EPS: $-4.33
• 52-Week High: $18.12
• 52-Week Low: $5.70

About ImageneBio, Inc.

ImageneBio, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, specializing in the development of innovative therapeutics for immunological and inflammatory diseases. The firm is dedicated to addressing significant unmet medical needs by utilizing advanced research and technology to create a robust product pipeline. Focused on transforming patient care, ImageneBio aims to deliver targeted treatment solutions that enhance therapeutic efficacy and improve cli...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ImageneBio, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMA pay dividends?

ImageneBio, Inc. (IMA) does not currently pay a regular dividend.

What is IMA's market cap?

ImageneBio, Inc. (IMA) has a market capitalization of $91.69M with a current stock price of $6.83.